PT841946E - Metodos para tratamento de asma alergica - Google Patents

Metodos para tratamento de asma alergica

Info

Publication number: PT841946E
Authority: PT; Portugal
Prior art keywords: treatment; methods; allergy asthma; allergy; asthma
Prior art date: 1995-07-27

Application number

PT96926134T

Other languages

English (en)

Inventor

Steven J Shire

Paula M Jardieu

Robert B Fick Jr

Monika B Schoenhoff

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-27

Filing date

1996-07-24

Publication date

2003-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24021032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT841946(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-07-24 Application filed by Genentech Inc filed Critical Genentech Inc

2003-02-28 Publication of PT841946E publication Critical patent/PT841946E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Microbiology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PT96926134T 1995-07-27 1996-07-24 Metodos para tratamento de asma alergica PT841946E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US50801495A	1995-07-27	1995-07-27

Publications (1)

Publication Number	Publication Date
PT841946E true PT841946E (pt)	2003-02-28

Family

ID=24021032

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT96926134T PT841946E (pt)	1995-07-27	1996-07-24	Metodos para tratamento de asma alergica

Country Status (16)

Country	Link
EP (1)	EP0841946B2 (pt)
JP (1)	JP4153560B2 (pt)
CN (2)	CN101172099B (pt)
AR (1)	AR003468A1 (pt)
AT (1)	ATE225185T1 (pt)
AU (1)	AU715338B2 (pt)
CA (1)	CA2226624C (pt)
DE (1)	DE69624116T3 (pt)
DK (1)	DK0841946T4 (pt)
ES (1)	ES2186796T5 (pt)
IL (1)	IL122733A (pt)
MX (1)	MX9800760A (pt)
PT (1)	PT841946E (pt)
RU (1)	RU2229288C2 (pt)
WO (1)	WO1997004807A1 (pt)
ZA (2)	ZA966075B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6685940B2 (en)	1995-07-27	2004-02-03	Genentech, Inc.	Protein formulation
US6267958B1 (en)	1995-07-27	2001-07-31	Genentech, Inc.	Protein formulation
US6171586B1 (en)	1997-06-13	2001-01-09	Genentech, Inc.	Antibody formulation
US6991790B1 (en)	1997-06-13	2006-01-31	Genentech, Inc.	Antibody formulation
WO1999045777A1 (en) *	1998-03-10	1999-09-16	The Children's Hospital Of Philadelphia	Compositions and methods for treatment of asthma
US6299875B1 (en) *	1998-06-04	2001-10-09	Panacea Pharmaceuticals, Llc	Methods to block IGE binding to cell surface receptors of mast cells
US6913749B2 (en)	1998-11-02	2005-07-05	Resistentia Pharmaceuticals Ab	Immunogenic polypeptides for inducing anti-self IgE responses
US8703126B2 (en)	2000-10-12	2014-04-22	Genentech, Inc.	Reduced-viscosity concentrated protein formulations
CA2423227C (en) *	2000-10-12	2011-11-29	Genentech, Inc.	Reduced-viscosity concentrated protein formulations
AU2003283137B8 (en)	2002-11-08	2010-07-29	Ablynx N.V.	Camelidae antibodies against immunoglobulin E and use thereof for the treatment of allergic disorders
EP2284192A3 (en)	2002-11-08	2011-07-20	Ablynx N.V.	Camelidae antibodies for sublingual administration
JO3000B1 (ar)	2004-10-20	2016-09-05	Genentech Inc	مركبات أجسام مضادة .
DE102006009437A1 (de) *	2006-03-01	2007-09-13	Bioceuticals Arzneimittel Ag	G-CSF-Flüssigformulierung
AU2008211807B2 (en) *	2007-01-29	2013-09-19	Valtion Teknillinen Tutkimuskeskus	Method for producing novel IgE based reagents
AR065368A1 (es)	2007-02-15	2009-06-03	Astrazeneca Ab	Anticuerpos para moleculas de ige
EP2052736A1 (en) *	2007-10-26	2009-04-29	Nycomed Danmark ApS	Parathyroid hormone formulations und uses thereof
WO2009082648A1 (en) *	2007-12-21	2009-07-02	Inspiration Biopharmaceuticals, Inc.	Stabilized factor ix formulations containing trehalose
CN101896163A (zh) *	2007-12-21	2010-11-24	弗·哈夫曼-拉罗切有限公司	抗体制剂
DK2279007T3 (en)	2008-04-29	2016-08-22	Ascendis Pharma Growth Disorders Div As	Pegylated recombinant relations of human growth hormone
AR073997A1 (es) *	2008-10-29	2010-12-15	Wyeth Corp	Formulaciones de moleculas de union a antigeno de dominio unico. metodo. kit
AU2009314311B2 (en)	2008-10-29	2013-01-10	Ablynx N.V.	Methods for purification of single domain antigen binding molecules
CA2783296C (en)	2009-12-15	2019-01-15	Ascendis Pharma As	Growth hormone composition
EP3372617B1 (en)	2010-04-02	2024-07-24	Amunix Pharmaceuticals, Inc.	Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
CN102533704A (zh) *	2010-12-30	2012-07-04	上海雅心生物技术有限公司	即配即用型的胰蛋白酶制剂
ES2676205T3 (es) *	2011-03-31	2018-07-17	Merck Sharp & Dohme Corp.	Formulaciones estables de anticuerpos para el receptor PD-1 humano de muerte programada y tratamientos relacionados
EP4088736A1 (en) *	2011-10-25	2022-11-16	Prothena Biosciences Limited	Humanized anti-amyloid antibody formulations and methods
MX2016003705A (es)	2013-09-27	2016-05-16	Hanmi Pharm Ind Co Ltd	Formulacion de un conjugado de hormona del crecimiento humana de accion prolongada.
CN104707146B (zh) *	2013-12-16	2019-04-16	浙江海正药业股份有限公司	一种含有阿达木单抗的药物组合物
LT3653227T (lt)	2014-11-18	2021-03-25	Ascendis Pharma Endocrinology Division A/S	Nauji polimeriniai hgh provaistai
EP3220892B1 (en)	2014-11-21	2021-10-13	Ascendis Pharma Endocrinology Division A/S	Long-acting growth hormone dosage forms
GB201610198D0 (en)	2016-06-10	2016-07-27	Ucb Biopharma Sprl	Anti-ige antibodies
JOP20190260A1 (ar)	2017-05-02	2019-10-31	Merck Sharp & Dohme	صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
RU2019138507A (ru)	2017-05-02	2021-06-02	Мерк Шарп И Доум Корп.	Составы антител против lag3 и совместные составы антител против lag3 и антител против pd-1
US11273205B2 (en)	2017-07-25	2022-03-15	Jiangsu Hengrui Medicine Co., Ltd.	IL-15 protein complex pharmaceutical composition
BR112020016172A2 (pt) *	2018-02-09	2020-12-15	Genentech, Inc.	Métodos de tratamento, métodos para determinar, métodos para selecionar uma terapia, métodos para avaliar uma resposta e monitorar a resposta, kits para identificar um paciente, agentes selecionados, agentes para uso, uso de um agente selecionado e uso de um antagonista
CN110732023B (zh) *	2018-07-18	2023-06-16	江苏恒瑞医药股份有限公司	一种her2抗体药物组合物及其用途
SG11202108735QA (en)	2019-03-04	2021-09-29	Ascendis Pharma Endocrinology Div A/S	Long-acting growth hormone dosage forms with superior efficacy to daily somatropin
CN113827717A (zh) *	2020-06-23	2021-12-24	三生国健药业（上海）股份有限公司	抗her2单克隆抗体冻干制剂及制备方法
JP2023541217A (ja)	2020-07-10	2023-09-29	シャンハイジェミンケアファーマシューティカルカンパニー，リミティド	抗ＩｇＥ改変抗体及びその適用
TW202409078A (zh) *	2022-07-18	2024-03-01	中國大陸商蘇州創勝醫藥集團有限公司	穩定之包含抗gremlin1抗體的藥物製劑

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3729863A1 (de) *	1987-09-05	1989-03-16	Boehringer Mannheim Gmbh	Stabilisierte erythropoietin-lyophilisate
AU616916B2 (en) *	1987-11-20	1991-11-14	Kissei Pharmaceutical Co. Ltd.	4h-quinolizin-4-one compounds exhibiting therapeutic activities
AU618317B2 (en) *	1987-12-31	1991-12-19	Tanox Biosystems, Inc.	Unique antigenic epitopes on ige-bearing b lymphocytes
US5011676A (en) *	1990-03-27	1991-04-30	Thomas Jefferson University	Method to directly radiolabel antibodies for diagnostic imaging and therapy
US5290764A (en) *	1992-01-14	1994-03-01	The Dupont Merck Pharmaceutical Company	Stabilization of active plasminogen activator inhibitor-1
WO1993019197A1 (en) *	1992-03-20	1993-09-30	Immunet	Human monoclonal antibodies and methods for human monoclonal antibody production
JPH07118168A (ja) *	1993-10-19	1995-05-09	Tomoyasu Ra	ＩｇＥ産生抑制剤
ATE264388T1 (de) *	1992-09-24	2004-04-15	Tanox Biosystems Inc	Umgestaltete monoklonale antikörper gegen ein immunglobulinisotyp
DE4344824C1 (de) *	1993-12-28	1995-08-31	Immuno Ag	Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
FR2719479B1 (fr) *	1994-05-04	1996-07-26	Sanofi Elf	Formulation stable lyophilisée comprenant une protéine: kit de dosage.

1996
- 1996-07-17 ZA ZA9606075A patent/ZA966075B/xx unknown
- 1996-07-23 RU RU98103237/15A patent/RU2229288C2/ru not_active IP Right Cessation
- 1996-07-23 CN CN2007101928065A patent/CN101172099B/zh not_active Expired - Lifetime
- 1996-07-23 ZA ZA9606240A patent/ZA966240B/xx unknown
- 1996-07-23 CN CNA2007101928120A patent/CN101172100A/zh active Pending
- 1996-07-24 AU AU66381/96A patent/AU715338B2/en not_active Expired
- 1996-07-24 IL IL12273396A patent/IL122733A/en not_active IP Right Cessation
- 1996-07-24 ES ES96926134T patent/ES2186796T5/es not_active Expired - Lifetime
- 1996-07-24 JP JP50775897A patent/JP4153560B2/ja not_active Expired - Lifetime
- 1996-07-24 EP EP96926134A patent/EP0841946B2/en not_active Expired - Lifetime
- 1996-07-24 WO PCT/US1996/012275 patent/WO1997004807A1/en not_active Ceased
- 1996-07-24 DK DK96926134T patent/DK0841946T4/da active
- 1996-07-24 CA CA2226624A patent/CA2226624C/en not_active Expired - Lifetime
- 1996-07-24 DE DE69624116T patent/DE69624116T3/de not_active Expired - Lifetime
- 1996-07-24 MX MX9800760A patent/MX9800760A/es active IP Right Grant
- 1996-07-24 PT PT96926134T patent/PT841946E/pt unknown
- 1996-07-24 AT AT96926134T patent/ATE225185T1/de active
- 1996-07-25 AR ARP960103741A patent/AR003468A1/es unknown

Also Published As

Publication number	Publication date
CA2226624A1 (en)	1997-02-13
MX9800760A (es)	1998-04-30
DK0841946T4 (da)	2009-02-16
IL122733A0 (en)	1998-08-16
WO1997004807A1 (en)	1997-02-13
AU715338B2 (en)	2000-01-20
ZA966240B (en)	1998-01-23
EP0841946B2 (en)	2008-10-15
ZA966075B (en)	1998-01-19
CN101172100A (zh)	2008-05-07
IL122733A (en)	2001-09-13
AR003468A1 (es)	1998-08-05
ES2186796T5 (es)	2009-04-01
AU6638196A (en)	1997-02-26
DE69624116T2 (de)	2003-06-18
JP4153560B2 (ja)	2008-09-24
JPH11510172A (ja)	1999-09-07
RU2229288C2 (ru)	2004-05-27
ATE225185T1 (de)	2002-10-15
CA2226624C (en)	2013-07-16
EP0841946A1 (en)	1998-05-20
CN101172099B (zh)	2012-02-15
DK0841946T3 (da)	2003-02-10
DE69624116D1 (de)	2002-11-07
CN101172099A (zh)	2008-05-07
DE69624116T3 (de)	2009-07-09
ES2186796T3 (es)	2003-05-16
EP0841946B1 (en)	2002-10-02

Publication	Publication Date	Title
PT841946E (pt)	2003-02-28	Metodos para tratamento de asma alergica
DE69635023D1 (de)	2005-09-08	Ulmwh (ultra-low-molecular weight heparin) zur behandlung von asthma
PT861081E (pt)	2002-06-28	Utilizacao de epinastina para o tratamento de dores
FI972922L (fi)	1997-07-09	Tarkkaamattomuuden ja yliaktiivisuuden hoito
DE69831755D1 (de)	2006-02-09	Optoakustische kontrastmittel und anwendungsverfahren
BR9509904A (pt)	1997-10-14	Processo para purificação e isolamento de 2-desóxi-2,2-difluor-nucleosideos
BR9504072A (pt)	1996-07-30	Composiçao farmacêutica métodos para o tratamento de hipercolesterolemia de aterosclerose e kit
NO20002075D0 (no)	2000-04-19	Fremgangsmõte ved aminering
ID30430A (id)	2001-12-06	Senyawa-senyawa dan metode-metode untuk pengobatan gangguan-gangguan asma, alergi dan inflamasi
DE69718808D1 (de)	2003-03-06	Plasmabehandlungsmethode
ID27214A (id)	2001-03-08	Triazolopiridina untuk pengobatan gangguan trombosis
PT827693E (pt)	2002-08-30	Produto de guarnicao para pastelaria-biscoiteria-confeitaria processo de fabrico e produto composto guarnecido
DE69717846D1 (de)	2003-01-23	Behandlungsverfahren von laktamen
ID18300A (id)	1998-03-26	Metoda penemperan
PT1051172E (pt)	2005-03-31	Metodo para tratamento da dpco
BR9608595A (pt)	1999-01-05	Utilização de n-cicloexil benzamidas para o tratamento de aglições intestinais
BR9804794A (pt)	1999-08-17	Processo para prepara-Æo de 1-alquil-4-(2-cloro-3-alcÄxi-4-alquil-sulfonil-benzoil) -5-hidrÄxi-pirazol e compostos relacioonados
DE59602924D1 (de)	1999-10-07	Knochenraspel
NO20006383D0 (no)	2000-12-14	Fremgangsmåte for behandling
BR9703439A (pt)	1999-01-05	Processos e aparelho para expansão de tabaco
ID24439A (id)	2000-07-20	Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID21244A (id)	1999-05-12	PENGOBATAN ASMA DENGAN TNFR-Ig
UA25504A (uk)	1998-12-25	Спосіб лікуваhhя дисбактеріозу hосоглотки
ID24521A (id)	2000-07-20	Penggunaan tiazolidindion untuk pengobatan hiperglikemia
PT1014810E (pt)	2003-09-30	Processo para o tratamento de tabaco